Loading...
XHKG1612
Market cap32mUSD
Jan 07, Last price  
0.40HKD
1D
-1.25%
1Q
-12.22%
Jan 2017
-63.43%
IPO
-66.24%
Name

Vincent Medical Holdings Ltd

Chart & Performance

D1W1MN
XHKG:1612 chart
P/E
4.44
P/S
0.35
EPS
0.09
Div Yield, %
3.16%
Shrs. gr., 5y
0.25%
Rev. gr., 5y
8.03%
Revenues
718m
+14.10%
324,492,000388,977,000448,169,000467,347,000446,302,000488,030,000502,200,0001,155,383,000777,720,000629,242,000717,973,000
Net income
57m
P
23,413,00035,759,00058,153,00029,242,00013,155,00030,943,00011,525,000216,865,00060,695,000-17,398,00057,275,000
CFO
125m
+63.85%
41,251,00043,997,00054,551,00021,507,000-17,584,00035,073,00031,319,000204,772,000119,433,00076,273,000124,975,000
Dividend
Sep 03, 20240.016 HKD/sh

Profile

Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
IPO date
Jul 13, 2016
Employees
1,262
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
717,973
14.10%
629,242
-19.09%
Cost of revenue
669,441
651,744
Unusual Expense (Income)
NOPBT
48,532
(22,502)
NOPBT Margin
6.76%
Operating Taxes
8,707
2,874
Tax Rate
17.94%
NOPAT
39,825
(25,376)
Net income
57,275
-429.20%
(17,398)
-128.66%
Dividends
(8,042)
(32,686)
Dividend yield
3.24%
7.69%
Proceeds from repurchase of equity
(3,273)
(2,436)
BB yield
1.32%
0.57%
Debt
Debt current
35,546
55,292
Long-term debt
18,178
10,200
Deferred revenue
(6,415)
Other long-term liabilities
6,415
Net debt
(154,880)
(124,042)
Cash flow
Cash from operating activities
124,975
76,273
CAPEX
(63,695)
(18,599)
Cash from investing activities
(62,366)
(18,609)
Cash from financing activities
(45,367)
(67,836)
FCF
20,272
52,185
Balance
Cash
175,784
159,341
Long term investments
32,820
30,193
Excess cash
172,705
158,072
Stockholders' equity
381,382
336,904
Invested Capital
407,771
379,389
ROIC
10.12%
ROCE
8.29%
EV
Common stock shares outstanding
645,661
653,741
Price
0.39
-40.77%
0.65
-35.00%
Market cap
248,579
-41.50%
424,932
-35.73%
EV
94,947
301,492
EBITDA
87,184
18,450
EV/EBITDA
1.09
16.34
Interest
1,682
2,852
Interest/NOPBT
3.47%